Steven B. Maron

First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial

Yelena Y. Janjigian, Steven B. Maron, Walid K. Chatila et al. · The Lancet Oncology · 2020 · 357 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma

Eirini Pectasides, Matthew D. Stachler, Sarah Derks et al. · Cancer Discovery · 2017 · 303 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma

Steven B. Maron, Leah M. Chase, Samantha Lomnicki et al. · Clinical Cancer Research · 2019 · 229 citations · Full text

Medicine, Genetics, Oncology +14

Nonoperative Management of Mismatch Repair–Deficient Tumors

Andrea Cercek, Michael B. Foote, Benoı̂t Rousseau et al. · New England Journal of Medicine · 2025 · 156 citations · Full text

Medicine, Oncology, Surgery +17

Automated real-world data integration improves cancer outcome prediction

Justin Jee, Christopher J. Fong, Karl Pichotta et al. · Nature · 2024 · 154 citations · Full text

Medicine, Biomedical Informatics, Oncology +13